KEMADRIN

This brand name is authorized in Austria, Ireland, Israel, Malta, New Zealand, United Kingdom

Active ingredients

The drug KEMADRIN contains one active pharmaceutical ingredient (API):

1 Procyclidine UNII CQC932Z7YW - PROCYCLIDINE HYDROCHLORIDE

Procyclidine is a synthetic anticholinergic agent which blocks the excitatory effects of acetylcholine at the muscarinic receptor. Procyclidine is used for the treatment and symptomatic relief of all forms of Parkinson’s disease and also to control troublesome extra-pyramidal symptoms induced by neuroleptic drugs.

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
KEMADRIN Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
KEMADRIN Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N04AA04	Procyclidine	N Nervous system → N04 Anti-parkinson drugs → N04A Anticholinergic agents → N04AA Tertiary amines
Discover more medicines within N04AA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 15436, 15439, 185873
Country: IE	Health Products Regulatory Authority	Identifier(s): 30015
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 2470
Country: MT	Medicines Authority	Identifier(s): MA955/00401
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 81